Leeds NHS innovation and Epredia partner to spread AI pathology globally; Cambridge start-up now in 15 NHS trusts
Leeds NHS innovation is spreading AI-based pathology in cancer diagnostics through a partnership with Epredia. A Cambridge AI start-up has grown from a single pilot to 15 NHS trusts.
Who is affected and how
- doctor
- AI pathology and the assessment of scanned slides are entering the cancer diagnostic workflow.
- medtech company
- NHS-level scaling offers an example of moving from a pilot to multi-trust deployment.
Sources
- Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnershipbusiness wire · Aug 5, 2026
- AI Pathology for Cancer Diagnostics via Leeds-Eprediahealthtechinsiders.com · Aug 6, 2026
- Cambridge AI start-up scales from single pilot to 15 NHS trustshome | digital health · Aug 3, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.